Scroll to top

Orchidia Pharmaceuticals

SPE Capital

Orchidia Pharmaceuticals Industries (OPI) is the sole local branded pharmaceutical player specialized in the ophthalmic segment in Egypt. Initially a service provider to multinational companies, Orchidia transformed itself into a full-fledged ophthalmologic player, successfully and advantageously competing with multinational companies such as Novartis and commanding the second market share.

  • Country:


  • Fund:

    Intaj II

  • Date:

    January 2013

  • Fund shareholding:

    Significant minority stake

  • Sector:


  • Exit date:

    Exited in December 2017

Share project
Open Website